MoonLake Immunotherapeutics (MLTX) — Financial Flexibility Index
MoonLake Immunotherapeutics (MLTX) has a Financial Flexibility Index of -0.49x as of December 2025. Free cash flow of $-58.79 Million (operating CF $-58.79 Million minus capex $0.00) represents 0% of total liabilities ($119.95 Million). Also explore net asset momentum of MoonLake Immunotherapeutics to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MoonLake Immunotherapeutics Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for MoonLake Immunotherapeutics across 6 annual periods. Check MoonLake Immunotherapeutics strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for MoonLake Immunotherapeutics (2020–2025)
Year-by-year free cash flow to debt coverage for MoonLake Immunotherapeutics. For the full company profile including market capitalisation, see MoonLake Immunotherapeutics market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.63x | $-195.97 Million | $-196.01 Million | $119.95 Million | ▲ +65.5% |
| 2024 | -4.73x | $-116.07 Million | $-116.59 Million | $24.54 Million | ▼ -45.2% |
| 2023 | -3.26x | $-42.49 Million | $-42.78 Million | $13.05 Million | ▲ +52.9% |
| 2022 | -6.92x | $-55.88 Million | $-55.89 Million | $8.08 Million | ▼ -320.1% |
| 2021 | -1.65x | $-35.12 Million | $-35.18 Million | $21.33 Million | ▼ -2058.2% |
| 2020 | -0.08x | $-316.69K | $-316.69K | $4.15 Million | — |